>(*) USA Approval Date: 2020. 02.21
>ACL: Adenosine triphosphate-Citrat
>Indication:
>Mechanism: ACL Inhibitor.
>Patent>Assignee; Claims; No.; Etc.
>Patent>Total USA No.: 6
>Patent>UpDate: 2020. 02.25.
>TradeMark
>TradeMark Web-Site